Thread
:
TDM1 Associate Marketing Director Position
View Single Post
04-08-2011, 06:23 AM
#
4
schoonder
Senior Member
Join Date: Jul 2008
Posts: 186
Re: TDM1 Associate Marketing Director Position
Roche reports the T-DM1 arm in its 1st-line HER2+ MBC phaseII trial had significantly longer progression free survival time, with less side effects than the Herceptin-Docetaxel arm.
http://www.morningstar.co.uk/uk/mark...38501957978184
schoonder
View Public Profile
Send a private message to schoonder
Find More Posts by schoonder